APRIL CAR T Cells (AUTO2) Targeting BCMA and TACI for the Treatment of Multiple Myeloma

NCT03287804 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
12
Enrollment
INDUSTRY
Sponsor class

Stopped Preliminary efficacy seen to date following treatment with AUTO2 has been determined not sufficient to warrant further development

Conditions

Interventions

Sponsor

Autolus Limited